Dr app: smartphone apps effective for depression


Wednesday, 04 October, 2017

Dr app: smartphone apps effective for depression

While ‘Dr Google’ may not be the safest way to self-diagnose and medicate, research has shown that purpose-built smartphone apps are an effective treatment option for depression.

New Australian-led research has confirmed that smartphone apps could pave the way for safe and accessible interventions for the millions of people around the world diagnosed with this condition.

Depression is the most prevalent mental disorder and a leading cause of global disability, with mental health services worldwide struggling to meet the demand for treatment.1

In an effort to tackle this rising challenge, researchers from Australia’s National Institute of Complementary Medicine (NICM), Harvard Medical School, The University of Manchester and the Black Dog Institute in Australia examined the efficacy of smartphone-based treatments for depression.

The researchers systematically reviewed 18 randomised controlled trials which examined a total of 22 different smartphone-delivered mental health interventions.

The studies involved more than 3400 male and female participants between the ages of 18–59 with a range of mental health symptoms and conditions including major depression, mild to moderate depression, bipolar disorder, anxiety and insomnia.

The first of its kind research, recently published in World Psychiatry, found that overall smartphone apps significantly reduced people’s depressive symptoms, suggesting these new digital therapies can be useful for managing the condition.

The lead author of the paper, NICM postdoctoral research fellow Joseph Firth, said this was an important finding which presented a new opportunity for providing accessible and affordable care for patients who might not otherwise have access to treatment.

“The majority of people in developed countries own smartphones, including younger people who are increasingly affected by depression,” said Firth.

“Combined with the rapid technological advances in this area, these devices may ultimately be capable of providing instantly accessible and highly effective treatments for depression, reducing the societal and economic burden of this condition worldwide.”

Professor Jerome Sarris, co-author and NICM deputy director, highlighted the importance of the findings for opening up non-stigmatising and self-managing avenues of care.

“The data shows us that smartphones can help people monitor, understand and manage their own mental health. Using apps as part of an ‘integrative medicine’ approach for depression has been demonstrated to be particularly useful for improving mood and tackling symptoms in these patients,” said Professor Sarris.

When it comes to the question of “Which app is best?” and “For who?”, the results suggested these interventions so far may be most applicable to those with mild to moderate depression, as the benefits in major depression have not been widely studied as of yet.

The researchers found no difference in apps which apply principles of mindfulness compared to cognitive behavioural therapy or mood monitoring programs.

However, interventions that used entirely ‘self-contained’ apps — meaning the app did not reply on other aspects such as clinician and computer feedback — were found to be significantly more effective than ‘non-self-contained’ apps.

The authors suggested this might be due to the comprehensiveness of these particular standalone apps rather than the combination of therapies.

Despite the promising early results, there is currently no evidence to suggest that using apps alone can outperform standard psychological therapies, or reduce the need for antidepressant medications.

1. World Health Organization. (2017). Depression and other common mental disorders: global health estimates. Geneva.

Image credit: ©iStockphoto.com/Global Stock

Originally published here.

Related News

Non-invasive 'virtual' biopsy for skin cancer diagnosis

Researchers have developed a new imaging method that allows clinicians to analyse the skin...

UTI vaccines could prevent infection for nine years

MV140 is a new vaccine for recurrent UTIs and is administered with two sprays of a...

What's the key to retaining rural GPs?

Understanding doctors' decisions to stay or leave, once recruited, could provide insights on...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd